|
ARN Name :
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Scheme Positioning
• A portfolio largely of market leaders in their respective product segments and focused-line businesses in larger markets that are likely to be tomorrow's large caps.
• A portfolio of companies with high growth potential and a robust balance sheet to support such growth. 12 Month Market Capitalization Trend (% to Equity Holdings) 
As per the Market Capitalization data provided by AMFI (In line with the applicable SEBI guidelines)
Data as on November 30, 2022 Significant Portfolio changes of the Current Month
Note: The companies/stock(s) referred above are only for the purpose of disclosure of significant portfolio changes during the month and should not be construed as recommendation to buy/sell/ hold. The fund manager may or may not choose to hold these companies/stocks, from time to time. Investors are requested to consult their financial, tax and other advisors before taking any investment decision(s). Data as on November 30, 2022 |
Portfolio Update for the Month
• Key Overweight sector/Industries includes Automobiles and auto components, Capital goods and Construction materials vs the Schemes’ Benchmark
Asset Allocation (%)
• Key Underweights sectors /Industries includes Healthcare, Banks and consumer durable vs the Schemes’ Benchmark. • Portfolio has added weight to select small cap stocks on the basis of bottom-up investment opportunities. 
Data as on November 30, 2022
Portfolio Stats
#Risk-free rate assumed to be 5.86% (MIBOR as on 30-11-22) - Source:www.mmda.org 1. Beta is calculated on the basis of average monthly rolling returns as of last day of the month since inception till November 30, 2022 and annualized. 2. Calculated for the period since inception till November 30, 2022. | Data Source: ICRA Analytics, Bloomberg | Data as on November 30, 2022 | N.A.: Net Assets |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Scheme Details
Investment Objective:
The investment objective of the Scheme is to seek to generate long term capital appreciation & provide long-term growth opportunities by investing in a portfolio constituted of equity & equity related securities and derivatives predominantly in mid cap companies. However, there can be no assurance that the investment objective of the Scheme will be achieved. Fund Manager: Mr. Abhinav Khandelwal Total Experience : 14 years Experience in managing this fund: 10 months (Managing since February 1, 2022) Mr. Manish Lodha Total Experience : 22 years, Experience in managing this fund: 1 year and 11 months (Managing since December 21, 2020) Date of allotment: January 30, 2018 Benchmark: Nifty Midcap 150 TRI Option: IDCW (IDCW Option will have IDCW Reinvestment (D) & IDCW Payout facility) and Growth (D) D-Default
Application Amount: Rs. 1,000 and in multiples of Re. 1/- thereafter
Additional Purchase Amount: Rs. 1,000/- and in multiples of Re. 1/- thereafter Repurchase Amount: Rs. 1,000/- or 100 units or account balance, whichever is lower Minimum Weekly & Monthly SIP Amount: Rs 500 and in multiples of Re. 1/- thereafter Minimum Weekly & Monthly SIP Installments: 6 Minimum Quarterly SIP Amount: Rs 1,500 and in multiples of Re. 1/- thereafter Minimum Quarterly SIP installments: 4 Monthly AAUM as on November 30, 2022 (Rs. in Cr.): 1,064.81 Monthly AUM as on November 30, 2022 (Rs. in Cr.): 1,078.22 Entry Load: Not applicable Exit Load: • An Exit Load of 1% is payable if Units are redeemed / switched-out upto 1 year from the date of allotment; • Nil if Units are redeemed / switched-out after 1 year from the date of allotment. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Scheme Performance (as on November 30, 2022) 
^Benchmark ^^Additional Benchmark. CAGR – Compounded Annual Growth Rate. Inception/Allotment date: 30-Jan-18. Past performance may or may not be sustained in future and should not be used as a basis of comparison with other investments. Since inception returns of the scheme is calculated on face value of Rs. 10 invested at inception. The performance details provided above are of Growth Option under Regular Plan. Different Plans i.e Regular Plan and Direct Plan under the scheme has different expense structure. *Based on standard investment of Rs. 10,000 made at the beginning of the relevant period. Mr. Abhinav Khandelwal is managing this fund since February 1, 2022. Mr. Manish Lodha is managing this fund since December 21, 2020. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
SIP Performance (as on November 30, 2022) 
^Benchmark ^^Additional Benchmark. CAGR – Compounded Annual Growth Rate. Inception/Allotment date: 30-Jan-18. Past performance may or may not be sustained in future and should not be used as a basis of comparison with other investments. Returns greater than 1 year period are compounded annualized. For SIP returns, monthly investment of equal amounts invested on the 1st business day of every month has been considered. CAGR Returns (%) are computed after accounting for the cash flow by using the XIRR method (investment internal rate of return). |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
M-#Mobile number# |E-#email.abc@gmail.com# |
Disclaimer : Readers of this material should rely on information / data arising out of their own investigations and advised to seek independent professional advice and arrive at an informed decision before making any investments. Neither Mahindra Manulife Investment Management Private Limited nor Mahindra Manulife Trustee Private Limited, its directors or associates shall be liable for any damages that may arise from the use of the information contained herein. Reach us at: Sadhana House, 1st Floor, 570, P.B. Marg, Worli, Mumbai - 400 018, India. Phone: +91-22-66327900, Fax: +91-22-66327932 Toll Free No.: 1800 419 6244 Website: www.mahindramanulife.com |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Performance of other schemes managed by the Fund Manager(s)  ^Benchmark CAGR – Compounded Annual Growth Rate. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Disclaimer : Readers of this material should rely on information / data arising out of their own investigations and advised to seek independent professional advice and arrive at an informed decision before making any investments. Neither Mahindra Manulife Investment Management Private Limited nor Mahindra Manulife Trustee Private Limited, its directors or associates shall be liable for any damages that may arise from the use of the information contained herein. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
